Literature DB >> 22033456

Determining nuclear localization of alpha-synuclein in mouse brains.

Z Huang1, Z Xu, Y Wu, Y Zhou.   

Abstract

Alpha-synuclein (α-Syn) is a major component of Lewy bodies, abnormal protein aggregates that are present in neurons of patients with Parkinson's disease and other neurological disorders. Despite intensive investigation, the in vivo role of α-Syn in physiological and pathological processes is not fully understood. This study addresses a current debate on the nuclear localization of α-Syn protein in the brain. To assess the specificity of various α-Syn antibodies, we compared their staining patterns in wild-type mouse brains with that of the α-Syn knock-out mice. Among five different α-Syn antibodies tested here, two generated intensive nuclear staining throughout the normal mouse brain. However, nuclear staining by these two antibodies was also present in neurons of the α-Syn knock-out mice. This provides evidence that the nuclear signal is not specifically related to the presence of α-Syn, but it rather results from the cross-reactivity of the two antibodies to some unknown antigens in neuronal nuclei. In mouse brain neurons, endogenous α-Syn proteins are primarily localized to neuronal processes and nerve terminals but present only at low levels in the cell bodies. This is different from a generally uniform distribution of exogenously expressed α-Syn in both cytoplasm and nuclei of heterologous cells and suggests that the neuritic enrichment of α-Syn in neurons may be mediated by their specific interactions with certain structural or molecular components in the neuropil.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22033456      PMCID: PMC3237852          DOI: 10.1016/j.neuroscience.2011.10.016

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  38 in total

1.  Localization of alpha-synuclein to identified fibers and synapses in the normal mouse brain.

Authors:  S Totterdell; G E Meredith
Journal:  Neuroscience       Date:  2005-08-19       Impact factor: 3.590

Review 2.  The role of alpha-synuclein in the pathogenesis of multiple system atrophy.

Authors:  Gregor K Wenning; Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2005-01-22       Impact factor: 17.088

3.  Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody.

Authors:  S Yu; X Li; G Liu; J Han; C Zhang; Y Li; S Xu; C Liu; Y Gao; H Yang; K Uéda; P Chan
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

4.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

5.  Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies.

Authors:  G Vivacqua; A Casini; R Vaccaro; F Fornai; S Yu; L D'Este
Journal:  J Chem Neuroanat       Date:  2010-12-21       Impact factor: 3.052

6.  Modulation of inactivation properties of CaV2.2 channels by 14-3-3 proteins.

Authors:  Yong Li; Yuying Wu; Yi Zhou
Journal:  Neuron       Date:  2006-09-21       Impact factor: 17.173

7.  Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity.

Authors:  Eirene Kontopoulos; Jeffrey D Parvin; Mel B Feany
Journal:  Hum Mol Genet       Date:  2006-09-07       Impact factor: 6.150

8.  Alpha-synuclein and chaperones in dementia with Lewy bodies.

Authors:  Ippolita Cantuti-Castelvetri; Jochen Klucken; Martin Ingelsson; Karunya Ramasamy; Pamela J McLean; Matthew P Frosch; Bradley T Hyman; David G Standaert
Journal:  J Neuropathol Exp Neurol       Date:  2005-12       Impact factor: 3.685

9.  Neural expression profile of alpha-synuclein in developing human cortex.

Authors:  T A Bayer; P Jäkälä; T Hartmann; R Egensperger; R Buslei; P Falkai; K Beyreuther
Journal:  Neuroreport       Date:  1999-09-09       Impact factor: 1.837

10.  Subcellular localisation of recombinant alpha- and gamma-synuclein.

Authors:  Christian G Specht; Cezar M Tigaret; Georg F Rast; Agnes Thalhammer; York Rudhard; Ralf Schoepfer
Journal:  Mol Cell Neurosci       Date:  2005-02       Impact factor: 4.314

View more
  14 in total

1.  Parkinson disease mutant E46K enhances α-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo.

Authors:  Martial Kamdem Mbefo; Mohamed-Bilal Fares; Katerina Paleologou; Abid Oueslati; Guowei Yin; Sandra Tenreiro; Madalena Pinto; Tiago Outeiro; Markus Zweckstetter; Eliezer Masliah; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2015-02-05       Impact factor: 5.157

2.  Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies.

Authors:  David J Koss; Daniel Erskine; Andrew Porter; Pawel Palmoski; Hariharan Menon; Olivia G J Todd; Marta Leite; Johannes Attems; Tiago F Outeiro
Journal:  Acta Neuropathol Commun       Date:  2022-07-06       Impact factor: 7.578

3.  Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

Authors:  Dora Games; Peter Seubert; Edward Rockenstein; Christina Patrick; Margarita Trejo; Kiren Ubhi; Benjamin Ettle; Majid Ghassemiam; Robin Barbour; Dale Schenk; Silke Nuber; Eliezer Masliah
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

4.  The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

Authors:  Mohamed-Bilal Fares; Nadine Ait-Bouziad; Igor Dikiy; Martial K Mbefo; Ana Jovičić; Aoife Kiely; Janice L Holton; Seung-Jae Lee; Aaron D Gitler; David Eliezer; Hilal A Lashuel
Journal:  Hum Mol Genet       Date:  2014-04-11       Impact factor: 6.150

Review 5.  A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson's disease: Emerging concepts and challenges.

Authors:  Velmarini Vasquez; Joy Mitra; Haibo Wang; Pavana M Hegde; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2019-12-18       Impact factor: 11.685

Review 6.  Alpha-synuclein function and dysfunction on cellular membranes.

Authors:  David Snead; David Eliezer
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

7.  Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders.

Authors:  Allison J Schaser; Valerie R Osterberg; Sydney E Dent; Teresa L Stackhouse; Colin M Wakeham; Sydney W Boutros; Leah J Weston; Nichole Owen; Tamily A Weissman; Esteban Luna; Jacob Raber; Kelvin C Luk; Amanda K McCullough; Randall L Woltjer; Vivek K Unni
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

8.  C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease.

Authors:  Alexandra Kleinknecht; Blagovesta Popova; Diana F Lázaro; Raquel Pinho; Oliver Valerius; Tiago F Outeiro; Gerhard H Braus
Journal:  PLoS Genet       Date:  2016-06-24       Impact factor: 5.917

Review 9.  Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?

Authors:  Abid Oueslati
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

Review 10.  Neurons and Glia Interplay in α-Synucleinopathies.

Authors:  Panagiota Mavroeidi; Maria Xilouri
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.